To exploit nutrient deprivation as anti-cancer therapy, we investigated the effects of the anti-metabolite 2-deoxy-D-glucose on breast cancer cells in vitro. This compound has been shown to ...

In a recent article posted to the bioRxiv* preprint server, scientists demonstrated the use of 2-deoxy-D-glucose (2-DG) as a wide-spectrum antiviral agent targeting viruses such as severe acute ...

2-deoxy-D-glucose (2DG) is known as a synthetic inhibitor of glucose. 2DG regulates various cellular responses including proliferation, apoptosis and differentiation by regulation of glucose ...

In April 2020, the scientists at INMAS-DRDO and CCMB, Hyderabad jointly conducted laboratory experiments and concluded that the molecule works effectively against the SARS-CoV-2 virus and inhibits ...

The Drugs Controller General of India (DCGI) earlier this month granted permission for the emergency use of 2-Deoxy-D-Glucose drug as an adjunct therapy in moderate-to-severe Covid patients.

The Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO has developed the drug 2-deoxy-D-glucose (2-DG), in collaboration with Dr Reddy’s Laboratories, Hyderabad for ...

DRDO Chairman G Satheesh Reddy has said that the second batch of the '2-deoxy-D-glucose' will be coming around by 27 May in a limited quantity. Speaking to news agency ANI, the DRDO Chairman said ...

DRDO's newly launched anti-COVID medicine, 2-deoxy-D-glucose is being hailed as an innovative holy grail for COVID patients in India right now, who are currently battling for their lives and ...

Four Covid patients in Nashik became the first in the city to be treated with the 2-deoxy-D-glucose (2-DG) oral drug in June. The treatment has shown good results. Dr Chopda said that the drug is ...